Autolus Therapeutics annual ebitda margin
2017
2018
2019
2022
2023
2024
2025
Autolus Therapeutics EBITDA Margin Growth & History (AUTL)
Autolus Therapeutics's ebitda margin was −347.86% for fiscal 2025.
View full Autolus Therapeutics company overviewAutolus Therapeutics annual ebitda margin history
| Fiscal year | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −347.86% | +1963.12 pp |
| 2024 | 2024-12-31 | −2,310.99% | +7885.48 pp |
| 2023 | 2023-12-31 | −10,196.47% | −8001.02 pp |
| 2022 | 2022-12-31 | −2,195.45% | — |
| 2019 | 2019-12-31 | −4,864.27% | — |
| 2018 | 2018-09-30 | −3,967.59% | −2643.96 pp |
| 2017 · Sep 30 | 2017-09-30 | −1,323.63% | — |
Autolus Therapeutics quarterly ebitda margin
Q1.19
Q2.19
Q3.19
Q3.19
Q4.19
Q1.20
Q2.20
Q1.21
Q1.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −91.22% | +191.41 pp |
| Q1 2026 | 2026-03-31 | −218.57% | +485.60 pp |
| Q4 2025 | 2025-12-31 | −289.53% | +254707.02 pp |
| Q3 2025 | 2025-09-30 | −328.12% | — |
| Q2 2025 | 2025-06-30 | −282.63% | — |
| Q1 2025 | 2025-03-31 | −704.16% | −337.99 pp |
| Q4 2024 | 2024-12-31 | −254,996.55% | — |
| Q1 2024 | 2024-03-31 | −366.18% | — |
| Q1 2021 | 2021-03-31 | −14,204.46% | −3168.37 pp |
| Q2 2020 | 2020-06-30 | −13,063.82% | −2216.49 pp |
| Q1 2020 | 2020-03-31 | −11,036.09% | −9584.06 pp |
| Q4 2019 | 2019-12-31 | −13,525.89% | −5294.47 pp |
| Q3 2019 · Sep 30 | 2019-09-30 | −11,608.08% | — |
| Q3 2019 · Jun 30 | 2019-06-30 | −10,847.34% | — |
| Q2 2019 | 2019-03-31 | −1,452.04% | — |
| Q1 2019 | 2018-12-31 | −8,231.42% | — |
Autolus Therapeutics ebitda margin trends
Between the periods ended 2017-09-30 and 2025-12-31, Autolus Therapeutics's ebitda margin increased from −1,323.63% to −347.86%, a change of +975.76 percentage points. The latest reported quarter, Q2 2026, shows −91.22%.
About the metric
What EBITDA margin means
EBITDA margin measures EBITDA as a percentage of revenue. It can help compare operating profitability over time, but it excludes capital intensity, financing costs, taxes, and other items and is generally unsuitable for financial companies.
Calculation and source
How EBITDA margin is calculated
TickerStat calculates EBITDA margin as EBITDA divided by positive reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Autolus Therapeutics source filings ↗